Leptin
HormonesWhat is Leptin?
Leptin is a 167-amino acid peptide hormone produced predominantly by white adipose tissue (fat cells). Often called the "satiety hormone," leptin signals the brain about the body's energy stores. When fat stores are adequate, leptin levels are high, communicating to the hypothalamus to reduce appetite and increase energy expenditure. When fat stores decrease, leptin drops, triggering hunger and energy conservation. Leptin acts primarily on the arcuate nucleus of the hypothalamus, inhibiting appetite-stimulating (orexigenic) neuropeptides like NPY and AgRP while activating appetite-suppressing (anorexigenic) signals like POMC and CART.
Leptin levels correlate strongly with body fat mass—individuals with more adipose tissue produce more leptin. Women typically have higher leptin levels than men at any given BMI due to greater subcutaneous fat. Leptin follows a diurnal pattern with peak levels during the night. The discovery of leptin in 1994 was a landmark in obesity research, but the initial hope that leptin administration would treat obesity was tempered by the finding that most obese individuals already have high leptin levels and are resistant to its effects—a condition termed leptin resistance.
Why It Matters
Leptin is central to understanding energy homeostasis and the pathophysiology of obesity. While congenital leptin deficiency is extremely rare, it causes severe childhood-onset obesity that is dramatically treatable with leptin replacement (metreleptin). Far more commonly, obesity is associated with leptin resistance—high leptin levels that fail to suppress appetite—making leptin a marker of adiposity and metabolic dysfunction. Leptin also plays roles in reproductive function (low leptin signals energy insufficiency and suppresses the reproductive axis), immune function, and bone metabolism. Clinically, leptin measurement is most useful in evaluating rare genetic obesity syndromes and lipodystrophy.
Normal Reference Ranges
| Group | Range | Unit |
|---|---|---|
| Men (normal BMI) | 1–5 | ng/mL |
| Women (normal BMI) | 7–13 | ng/mL |
| Obese Adults | 10–100+ | ng/mL |
Reference ranges may vary by laboratory. Always compare results to the ranges provided by your testing facility.
What High LEP Levels Mean
Common Causes
- Obesity (leptin levels correlate with fat mass)
- Leptin resistance (the most common scenario in obesity)
- Overeating and caloric excess
- Sleep deprivation (short-term elevation)
- Insulin resistance and metabolic syndrome
- Pregnancy (placental production)
Possible Symptoms
- Persistent hunger despite excess body fat (leptin resistance)
- Weight gain and difficulty losing weight
- Fatigue
- Elevated inflammatory markers
- Insulin resistance
- Often asymptomatic—high leptin itself does not cause symptoms but reflects excess adiposity
What to do: Elevated leptin in the context of obesity reflects leptin resistance rather than a treatable hormonal excess. There is currently no approved pharmacological treatment for leptin resistance. Management focuses on the underlying obesity: dietary modification, physical activity, behavioral therapy, and when appropriate, anti-obesity medications or bariatric surgery. Weight loss reduces leptin levels proportionally. Interestingly, the drop in leptin during weight loss may contribute to weight regain by increasing hunger and decreasing metabolic rate—one reason sustained weight loss is physiologically difficult. Research into overcoming leptin resistance (improving leptin transport across the blood-brain barrier, reducing hypothalamic inflammation) is ongoing.
What Low LEP Levels Mean
Common Causes
- Congenital leptin deficiency (extremely rare autosomal recessive condition)
- Generalized or partial lipodystrophy (loss of fat tissue)
- Severe caloric restriction or starvation
- Anorexia nervosa
- Excessive exercise with low body fat
- Hypothalamic amenorrhea
Possible Symptoms
- Insatiable appetite and severe childhood-onset obesity (congenital deficiency)
- Hypogonadism and delayed puberty
- Immune dysfunction and frequent infections
- Loss of menstrual periods in women
- Metabolic complications of lipodystrophy (severe insulin resistance, fatty liver, hypertriglyceridemia)
- Impaired bone health
What to do: True leptin deficiency is rare but treatable. Congenital leptin deficiency (mutations in the LEP gene) causes severe early-onset obesity with hyperphagia—metreleptin (recombinant leptin) replacement produces dramatic weight loss and restores reproductive and immune function. In lipodystrophy, metreleptin is FDA-approved to treat metabolic complications (diabetes, hypertriglyceridemia). In functional hypothalamic amenorrhea from low energy availability, low leptin signals reproductive suppression—treatment involves restoring energy balance through increased caloric intake and reduced exercise. Leptin administration has been studied in this context but is not a standard treatment.
When Is LEP Testing Recommended?
- When evaluating severe childhood-onset obesity with hyperphagia
- When congenital leptin deficiency or lipodystrophy is suspected
- When assessing hypothalamic amenorrhea in athletes or women with low body fat
- In research protocols evaluating metabolic regulation
Frequently Asked Questions
Related Biomarkers
Want your LEP levels analyzed?
Upload your lab results for an instant AI-powered breakdown of all your biomarkers.
Upload Lab Results →Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Reference ranges may vary between laboratories. Always consult your healthcare provider for interpretation of your specific test results.